Catalyst
Slingshot members are tracking this event:
GlycoMimetics' GMI-1271 Receives FDA Fast Track Designation for Treatment of Acute Myeloid Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GLYC |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 13, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acute Myeloid Leukemia, Fast Track Designation, Fda, Gmi-1271
